Published in Bull World Health Organ on January 01, 1991
Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis (2009) 4.05
Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. PLoS Negl Trop Dis (2012) 2.42
African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost. PLoS Negl Trop Dis (2013) 1.61
Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis. Parasit Vectors (2015) 1.14
Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment. PLoS One (2014) 1.08
Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination. BMC Public Health (2001) 1.06
Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa. Bull World Health Organ (1997) 1.02
Developing eradication investment cases for onchocerciasis, lymphatic filariasis, and human African trypanosomiasis: rationale and main challenges. PLoS Negl Trop Dis (2013) 0.96
Polymerase chain reaction pool screening used to compare prevalence of infective black flies in two onchocerciasis foci in northern Sudan. Am J Trop Med Hyg (2011) 0.93
Impact of combined large-scale ivermectin distribution and vector control on transmission of Onchocerca volvulus in the Niger basin, Guinea. Bull World Health Organ (1995) 0.90
Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results. Infect Dis Poverty (2016) 0.88
Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes. PLoS Negl Trop Dis (2017) 0.84
Modeling and biological control of mosquitoes. J Am Mosq Control Assoc (2007) 0.81
Modelling the health and economic impacts of the elimination of river blindness (onchocerciasis) in Africa. BMJ Glob Health (2017) 0.75
A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area. Bull World Health Organ (1986) 2.51
The reproductive lifespan of Onchocerca volvulus in West African savanna. Acta Trop (1991) 1.76
ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Comput Methods Programs Biomed (1990) 1.70
Large scale ivermectin distribution and its epidemiological consequences. Acta Leiden (1990) 1.51
Ocular onchocerciasis and intensity of infection in the community. I. West African savanna. Trop Med Parasitol (1989) 1.38
Onchocerciasis in Kenya 9, 11 and 18 years after elimination of the vector. Bull World Health Organ (1967) 1.34
Density-dependence in parasite transmission dynamics. Parasitol Today (1988) 1.15
The predicted and observed decline in onchocerciasis infection during 14 years of successful control of Simulium spp. in west Africa. Bull World Health Organ (1990) 1.08
Entomological results of vector control in the Onchocerciasis Control Programme. Acta Leiden (1990) 1.00
Prospective evaluation of onchocerciasis control strategies. Acta Leiden (1990) 0.90
Studies on biting Simulium damnosum s.l. at a breeding site in the Onchocerciasis Control Programme area during and after an interruption of insecticidal treatments. Tropenmed Parasitol (1981) 0.88
Migration studies in the onchocerciasis controlled areas of West Africa. Trop Med Parasitol (1990) 0.85
Epidemiological impact of vector control. I. Incidence and changes in prevalence and intensity of Onchocerca volvulus infection. Acta Leiden (1990) 0.83
Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol (2001) 10.16
Stepwise selection in small data sets: a simulation study of bias in logistic regression analysis. J Clin Epidemiol (1999) 6.66
A clinical prediction rule for renal artery stenosis. Ann Intern Med (1998) 4.32
Endoscopic colorectal cancer screening: a cost-saving analysis. J Natl Cancer Inst (2000) 3.92
Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med (2000) 3.25
Management of children with acute pharyngitis: a decision analysis. J Fam Pract (1992) 2.75
The outcome of bacterial arthritis: a prospective community-based study. Arthritis Rheum (1997) 2.56
A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area. Bull World Health Organ (1986) 2.51
Fat and female fecundity: prospective study of effect of body fat distribution on conception rates. BMJ (1993) 2.48
Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets. Med Decis Making (2001) 2.45
Limitations of sensitivity, specificity, likelihood ratio, and bayes' theorem in assessing diagnostic probabilities: a clinical example. Epidemiology (1997) 2.28
Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol (2002) 2.22
Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer. Br J Cancer (1991) 2.18
Risk factors for septic arthritis in patients with joint disease. A prospective study. Arthritis Rheum (1995) 2.15
Post-1950 mortality trends and medical care: gains in life expectancy due to declines in mortality from conditions amenable to medical intervention in The Netherlands. Soc Sci Med (1988) 2.11
Delaying childbearing: effect of age on fecundity and outcome of pregnancy. BMJ (1991) 2.09
Predicting mortality from cervical cancer after negative smear test results. BMJ (1992) 2.01
Can ivermectin mass treatments eliminate onchocerciasis in Africa? Bull World Health Organ (2002) 1.99
The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Comput Biomed Res (1999) 1.98
Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer (1991) 1.97
A model for breast cancer screening. Cancer (1990) 1.96
Application of treatment thresholds to diagnostic-test evaluation: an alternative to the comparison of areas under receiver operating characteristic curves. Med Decis Making (1997) 1.96
Quantitative studies on the dispersal of skin bacteria into the air. J Med Microbiol (1976) 1.85
The use of spatial analysis in mapping the distribution of bancroftian filariasis in four West African countries. Ann Trop Med Parasitol (2002) 1.84
Estimating the magnitude of STD cofactor effects on HIV transmission: how well can it be done? Sex Transm Dis (2001) 1.83
Reliability of the diagnosis of a first seizure. Neurology (1989) 1.82
The reproductive lifespan of Onchocerca volvulus in West African savanna. Acta Trop (1991) 1.76
Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg (1994) 1.74
Resection of small, residual retroperitoneal masses after chemotherapy for nonseminomatous testicular cancer: a decision analysis. Cancer (1999) 1.71
Perioperative mortality of elective abdominal aortic aneurysm surgery. A clinical prediction rule based on literature and individual patient data. Arch Intern Med (1995) 1.70
ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Comput Methods Programs Biomed (1990) 1.70
Regional differences in mortality from conditions amenable to medical intervention in The Netherlands: a comparison of four time periods. J Epidemiol Community Health (1988) 1.64
Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. J Infect Dis (1995) 1.58
The impact of a breast cancer screening programme on quality-adjusted life-years. Int J Cancer (1991) 1.57
Explorative study of costs, effects and savings of screening for female fragile X premutation and full mutation carriers in the general population. Community Genet (1998) 1.52
Large scale ivermectin distribution and its epidemiological consequences. Acta Leiden (1990) 1.51
Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York study. J Natl Cancer Inst (1986) 1.50
Model-based evaluation of single-round mass treatment of sexually transmitted diseases for HIV control in a rural African population. AIDS (2000) 1.50
The measurement of performance in probabilistic diagnosis. III. Methods based on continuous functions of the diagnostic probabilities. Methods Inf Med (1978) 1.49
Hip fracture in elderly patients: outcomes for function, quality of life, and type of residence. Clin Orthop Relat Res (2001) 1.48
Association between microfilarial load and excess mortality in onchocerciasis: an epidemiological study. Lancet (2004) 1.47
Use of Markov series and Monte Carlo simulation in predicting replacement valve performances. J Heart Valve Dis (1998) 1.47
Falls in dementia patients. Gerontologist (1993) 1.46
The force of measles infection in East Africa. Int J Epidemiol (1984) 1.45
Endocervical status is not predictive of the incidence of cervical cancer in the years after negative smears. Am J Clin Pathol (2001) 1.45
Inaccuracies in estimates of life expectancies of patients with bronchial cancer in clinical decision making. Med Decis Making (1993) 1.43
The validity of the postcoital test for estimating the probability of conceiving. Am J Obstet Gynecol (1994) 1.40
[What to do in a 60-year-old HIV-positive woman with a cerebral arteriovenous malformation? Decision analysis]. Ned Tijdschr Geneeskd (1995) 1.40
Pain and quality of life in patients with critical limb ischaemia: results of a randomized controlled multicentre study on the effect of spinal cord stimulation. ESES study group. Eur J Pain (2000) 1.40
A measure of survival time for long-term follow-up studies of the elderly. J Clin Epidemiol (1989) 1.39
[Serum screening in pregnant women for Down syndrome and open neural-tube defects; testing against the Health Council criteria for genetic screening]. Ned Tijdschr Geneeskd (1996) 1.39
Pseudouridines and pseudouridine synthases of the ribosome. Cold Spring Harb Symp Quant Biol (2001) 1.39
The MISCAN simulation program for the evaluation of screening for disease. Comput Methods Programs Biomed (1985) 1.39
Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. Bull World Health Organ (1989) 1.37
How cost-effective is breast cancer screening in different EC countries? Eur J Cancer (1993) 1.35
Economic aspects of cervical cancer screening. Soc Sci Med (1990) 1.34
The "utility" of the Time Trade-Off method in cancer patients: feasibility and proportional Trade-Off. J Clin Epidemiol (1995) 1.32
Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril (1999) 1.32
Onchocerca volvulus DNA probe classification correlates with epidemiologic patterns of blindness. J Infect Dis (1992) 1.32
Age-dependent decrease in embryo implantation rate after in vitro fertilization. Fertil Steril (1996) 1.27
Systematic selection of prognostic features in patients with severe head injury. Neurosurgery (1980) 1.27
A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the city of Florence, Italy. Eur J Cancer (1995) 1.27
Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab (1998) 1.26
Risk factors for seizure recurrence in children with febrile seizures: a pooled analysis of individual patient data from five studies. J Pediatr (1994) 1.25
Prognosis after aortic valve replacement with a bioprosthesis: predictions based on meta-analysis and microsimulation. Circulation (2001) 1.24
A pocket chart to estimate true Schistosoma mansoni prevalences. Parasitol Today (1993) 1.23
Advanced breast cancer and its prevention by screening. Br J Cancer (1992) 1.23
A model for variations in single and repeated egg counts in Schistosoma mansoni infections. Parasitology (1992) 1.22
The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana. Trans R Soc Trop Med Hyg (1995) 1.21
Diagnostic and treatment procedures induced by cervical cancer screening. Eur J Cancer (1990) 1.20
Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection. Parasitol Today (2000) 1.19
Estimated event-free life expectancy after autograft aortic root replacement in adults. Ann Thorac Surg (2001) 1.19
Validation of a prediction model and its predictors for the histology of residual masses in nonseminomatous testicular cancer. J Urol (2001) 1.17
Costs of medical care after first-ever stroke in The Netherlands. Stroke (1995) 1.16
Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol (2002) 1.16
The cost-effectiveness of breast cancer screening. Int J Cancer (1989) 1.16
Cost of care of patients with cystic fibrosis in The Netherlands in 1990-1. Thorax (1996) 1.16
Detection of Onchocerca volvulus infection in low prevalence areas: a comparison of three diagnostic methods. Parasitology (2002) 1.16